Core Viewpoint - The company, Boten Co., Ltd. (300363.SZ), plans to acquire a portion of shares in Shenzhen Yifeng Yunding Venture Capital Partnership (Limited Partnership) for a nominal price of 1 yuan, which will involve a capital contribution obligation of 20 million yuan as per the partnership agreement [1] Group 1: Investment Details - The acquisition will allow the company to indirectly invest in Hangzhou Yifeng Runjun Venture Capital Partnership (Limited Partnership) through the Yifeng Yunding Fund [1] - The Yifeng Yunding Fund specializes in investments in the healthcare sector, focusing on innovative drugs, high-end medical devices, and biotechnology [1] Group 2: Strategic Implications - This investment is expected to leverage the resources of a professional investment institution, aiding the company in business development and strategic resource acquisition [1] - The projects funded by the Yifeng Runjun Fund may present opportunities for business collaboration and synergies with the company [1]
博腾股份拟受让倚锋云鼎基金部分份额